Recombinant IGFBP7

Recombinant IGFBP7 has been studied in 2 papers since 2024: 2 observational studies in people; 1 in the past year. The newest story, Nov 7, 2026: “Mice lacking a protein released by cells had lower blood pressure”.

Intervention

2 papers study it2 findingsUpdated

1 new paper in 30 daysSee all 2 papers on recombinant IGFBP7

At a glance

The findings reach mice, none yet in people. 2 independent labs in 1 country.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.
  • 2 independent labs in 1 country
  • Funder: National Natural Science Foundation of China
  • Humans2

What did studies of recombinant IGFBP7 find?

2

Studies of recombinant IGFBP7 measured 2 outcomes; the most studied are endothelium-dependent relaxation (1 study) and cellular senescence (1).

Endothelium-dependent relaxation

downin mice1

1 study
  1. Recombinant IGFBP7 impairs endothelium-dependent relaxation in mice (Ex vivo acetylcholine-induced relaxation) (95.5±1.8% vs. 66.7±8.5%).

    “acute rIGFBP7 exposure impaired ACh-induced endothelium-dependent relaxation (95.5±1.8% vs. 66.7±8.5%, p<0.05)”

    AnimalsEx vivo acetylcholine-induced relaxationrecombinant proteinmesenteric arteryacute

    Mice lacking a protein released by cells had lower blood pressure

    AHA Scientific Sessions 2026 abstract

Cellular senescence

downin human cells1

1 study
  1. Recombinant IGFBP7 decreases cellular senescence in H2O2-induced DPFs.

    “Recombinant IGFBP7 reduced the senescence of H2O2-induced DPFs.”

    Cellsin H2O2-induced DPFs

    Insulin-like growth factor binding protein 7 identified in aged dental pulp by single-cell RNA sequencing

    Journal of advanced research

More on Cellular senescence

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months
AHA Scientific Sessions 2026 Abstract

Mice lacking a protein released by cells had lower blood pressure

Genetically altered mice also had lower levels of aldosterone, a hormone involved in blood pressure control, than unmodified controls.Genetically altered mice also had lower levels of aldosterone, a hormone involved in blood pressure control, than unmodified controls.

Mouse studyMechanisms